PE Weekly: Medical M&A Continues Strong
Urology, dermatology and mental health investment activity reflect an uptick in M&A activity toward the end of the first quarter.
Recent Deals
PE Weekly: Dealmakers Hit the Road with Latest M&A Deals
Street paving and traffic safety M&A add to ongoing flow of industrials and manufacturing deals
PE Weekly: Industrials and Manufacturing Add-Ons Continue to Lead
Middle-market M&A continues to focus on add-ons, while a $2 billion exit in the energy market also makes headlines
PE Weekly: Unilever Carveout May Signal Consumer M&A Opportunity
As enterprise services and manufacturing drive M&A volume, Unilever's sale of Suave could signal opportunity for consumer-focused transactions
PE Weekly: M&A Focuses on the Digital Enterprise
Dealmakers this week focus on a variety of tech-enabled B2B products and services driving digital transformation of the enterprise
The BD Teams Acting Like Sales Teams Are Closing More Deals
How a personalized approach can lead to more engagement with prospects
Dealmaking in the Year Ahead
Deal activity at the end of 2022 pointed to an expected slowdown, as investors focused on bright spots and took longer to scrutinize companies
PE Weekly: New Funds, Industrials Investments and Medical Exits
Several PE firms announced the close of new funds, while M&A activity saw investments across industrials and exits in medical
PE Weekly: Add-Ons Fuel M&A Activity
Add-on acquisitions seen across enterprise solutions, industrials and more, while Audax's newest fund anticipates more M&A demand ahead
PE Weekly: Healthcare Niches Fuel M&A Activity
M&A targets healthcare from pediatrics to senior care to ophthalmology, while the public sector emerges as a strong acquisition target this week
